| The biology of human natural killer-cell subsets MA Cooper, TA Fehniger, MA Caligiuri Trends in immunology 22 (11), 633-640, 2001 | 4030 | 2001 |
| Guidelines for the use of flow cytometry and cell sorting in immunological studies A Cossarizza, HD Chang, A Radbruch, A Acs, D Adam, S Adam‐Klages, ... European journal of immunology 49 (10), 1457-1973, 2019 | 1978 | 2019 |
| Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset MA Cooper, TA Fehniger, SC Turner, KS Chen, BA Ghaheri, T Ghayur, ... Blood, The Journal of the American Society of Hematology 97 (10), 3146-3151, 2001 | 1934 | 2001 |
| Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance X Cao, SF Cai, TA Fehniger, J Song, LI Collins, DR Piwnica-Worms, ... Immunity 27 (4), 635-646, 2007 | 1367 | 2007 |
| Interleukin 15: biology and relevance to human disease TA Fehniger, MA Caligiuri Blood, The Journal of the American Society of Hematology 97 (1), 14-32, 2001 | 1324 | 2001 |
| CD56bright natural killer cells are present in human lymph nodes and are activated by T cell–derived IL-2: a potential new link between adaptive and innate immunity TA Fehniger, MA Cooper, GJ Nuovo, M Cella, F Facchetti, M Colonna, ... Blood, The Journal of the American Society of Hematology 101 (8), 3052-3057, 2003 | 1106 | 2003 |
| TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ... New England Journal of Medicine 375 (21), 2023-2036, 2016 | 896 | 2016 |
| Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia R Romee, M Rosario, MM Berrien-Elliott, JA Wagner, BA Jewell, ... Science translational medicine 8 (357), 357ra123-357ra123, 2016 | 880 | 2016 |
| Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune … TA Fehniger, MH Shah, MJ Turner, JB VanDeusen, SP Whitman, ... The Journal of Immunology 162 (8), 4511-4520, 1999 | 848 | 1999 |
| Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect SS Farag, TA Fehniger, L Ruggeri, A Velardi, MA Caligiuri Blood, The Journal of the American Society of Hematology 100 (6), 1935-1947, 2002 | 765 | 2002 |
| Cytokine activation induces human memory-like NK cells R Romee, SE Schneider, JW Leong, JM Chase, CR Keppel, RP Sullivan, ... Blood, The Journal of the American Society of Hematology 120 (24), 4751-4760, 2012 | 707 | 2012 |
| NK cell and DC interactions MA Cooper, TA Fehniger, A Fuchs, M Colonna, MA Caligiuri Trends in immunology 25 (1), 47-52, 2004 | 614 | 2004 |
| In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells MA Cooper, JE Bush, TA Fehniger, JB VanDeusen, RE Waite, Y Liu, ... Blood, The Journal of the American Society of Hematology 100 (10), 3633-3638, 2002 | 577 | 2002 |
| A potential role for interleukin-15 in the regulation of human natural killer cell survival. WE Carson, TA Fehniger, S Haldar, K Eckhert, MJ Lindemann, CF Lai, ... The Journal of clinical investigation 99 (5), 937-943, 1997 | 527 | 1997 |
| Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs TA Fehniger, SF Cai, X Cao, AJ Bredemeyer, RM Presti, AR French, ... Immunity 26 (6), 798-811, 2007 | 509 | 2007 |
| Fatal Leukemia in Interleukin 15 Transgenic Mice Follows Early Expansions in Natural Killer and Memory Phenotype Cd8+ T Cells TA Fehniger, K Suzuki, A Ponnappan, JB VanDeusen, MA Cooper, ... The Journal of experimental medicine 193 (2), 219-232, 2001 | 492 | 2001 |
| First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation R Romee, S Cooley, MM Berrien-Elliott, P Westervelt, MR Verneris, ... Blood, The Journal of the American Society of Hematology 131 (23), 2515-2527, 2018 | 393 | 2018 |
| Interleukin-2 and interleukin-15: immunotherapy for cancer TA Fehniger, MA Cooper, MA Caligiuri Cytokine & growth factor reviews 13 (2), 169-183, 2002 | 392 | 2002 |
| Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets M Frey, NB Packianathan, TA Fehniger, ME Ross, WC Wang, CC Stewart, ... The Journal of Immunology 161 (1), 400-408, 1998 | 366 | 1998 |
| CD56bright NK cells exhibit potent antitumor responses following IL-15 priming JA Wagner, M Rosario, R Romee, MM Berrien-Elliott, SE Schneider, ... The Journal of clinical investigation 127 (11), 4042-4058, 2017 | 354 | 2017 |
Melissa M. Berrien-ElliottSaint Louis University School of MedicineZweryfikowany adres z health.slu.edu
